Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor ; volume:24 ; number:1 ; day:2 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
BMC cancer ; 24, Heft 1 (2.5.2024), 1-12, 12.2024

Urheber
Obinata, Daisuke
Takayama, Kenichi
Lawrence, Mitchell G.
Funakoshi, Daigo
Hara, Makoto
Niranjan, Birunthi
Teng, Linda
Taylor, Renea A.
Risbridger, Gail P.
Takahashi, Satoru
Inoue, Satoshi
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12885-024-12298-3
URN
urn:nbn:de:101:1-2407132121155.910658522998
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:55 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Obinata, Daisuke
  • Takayama, Kenichi
  • Lawrence, Mitchell G.
  • Funakoshi, Daigo
  • Hara, Makoto
  • Niranjan, Birunthi
  • Teng, Linda
  • Taylor, Renea A.
  • Risbridger, Gail P.
  • Takahashi, Satoru
  • Inoue, Satoshi
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer

Hochschulschrift

Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer

Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer

Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer

Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription

Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription

Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade

Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade

Targeting molecular resistance in castration-resistant prostate cancer

Targeting molecular resistance in castration-resistant prostate cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Osteoclasts directly influence castration-resistant prostate cancer cells

Osteoclasts directly influence castration-resistant prostate cancer cells

Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial

Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial

The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2

The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2

Effect of simvastatin on castration-resistant prostate cancer cells

Effect of simvastatin on castration-resistant prostate cancer cells

Ureter metastatic castration-resistant prostate cancer: a case report

Ureter metastatic castration-resistant prostate cancer: a case report

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Verbundene Objekte